JP MORGAN/CALL/ABBOTT LABORATORIES/160/0.1/16.01.26 Share Price

Warrant

DE000JK50Z80

Market Closed - Börse Stuttgart 07:35:09 03/06/2024 pm IST
0.11 EUR +17.02% Intraday chart for JP MORGAN/CALL/ABBOTT LABORATORIES/160/0.1/16.01.26
1 month-35.29%
Date Price Change
03/24/03 0.11 +17.02%
31/24/31 0.094 +11.90%
30/24/30 0.084 -8.70%
29/24/29 0.092 -16.36%
28/24/28 0.11 0.00%

Delayed Quote Börse Stuttgart

Last update June 03, 2024 at 07:35 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JK50Z8
ISINDE000JK50Z80
Date issued 04/04/2024
Strike 160 $
Maturity 16/01/2026 (592 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.27
Lowest since issue 0.084
Spread 0.06
Spread %37.50%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
102.9 USD
Average target price
125.4 USD
Spread / Average Target
+21.88%
Consensus